BahVideo.com
Derek Stewart OBE - NCRI Consumer Liaison Group, UK
Derek Stewart OBE - NCRI Consumer Liaison Group UK | BahVideo.com
Watch Derek Stewart OBE - NCRI Consumer Liaison Group,  UK

Derek Stewart OBE - NCRI Consumer Liaison Group, UK

0 of 5 Stars
Derek Stewart, a former cancer patient, speaks about his work with the Consumer Liason Group providing a patient perspective for cancer research groups and cancer services. This group allows patients to have involvement in clinical trial design to help the trials appeal to patients. The patients' perspective had traditionally been neglected when designing trials and trial recruitment is at a low across the whole of Europe and America. Mr Stewart explains why patient involvement is essential if trials are to recruit the maximum number of patients possible and talks about the different ways that cancer patients can find clinical trials to join. Mr Stewart discusses why he feels patient uptake for clinical trials in the UK is higher than in mainland Europe, explains how patients can improve clinical trials, talks about the NCRI review of patient quality of life and care after completion of cancer treatment and stresses the need for more GP involvement in the care programme of their patients.
Channel: www.ecancer.tv
Video Length: 0
Date Found: January 11, 2011
Category: Science
Date Produced:
View Count: 0
Flag
Related Videos
Prof Mathias Rummel - Klinikum der Justus-Liebig-Universität,  Giessen, Germany | BahVideo.com
www.ecancer.tv

Prof Mathias Rummel - Klinikum der Justus-Liebig-Universität, Giessen, Germany

0 of 5 Stars
March 01, 2011
Prof Mathias Rummel discusses his research demonstrating the efficacy of bendamustine plus rituximab as a treatment for mantle cell lymphomas (MCL). Following the results presented at ASH 2009 revealing the superiority of bendamustine plus rituximab over CHOP plus rituximab as first line ...
Chair: Prof Meletios Dimopoulos - Univeristy of Athens,  Greece; Prof Hermann Einsele - Medizinische Klinik II, Wurzburg, Germany; Prof Mario Boccadoro - University of Turin, Italy; Dr Maria-Victoria | BahVideo.com
www.ecancer.tv

Chair: Prof Meletios Dimopoulos - Univeristy of Athens, Greece; Prof Hermann Einsele - Medizinische Klinik II, Wurzburg, Germany; Prof Mario Boccadoro - University of Turin, Italy; Dr Maria-Victoria

0 of 5 Stars
March 01, 2011
The panel discuss how the results of recent clinical trials have advanced our understanding of the optimal treatment for multiple myeloma. The development of new combinations containing drugs such as thalidomide, bortezomib and lenalidomide is helping clinicians achieve complete remission and ...
Prof Mathias Rummel - Klinikum der Justus-Liebig-Universität,  Giessen, Germany | BahVideo.com
www.ecancer.tv

Prof Mathias Rummel - Klinikum der Justus-Liebig-Universität, Giessen, Germany

0 of 5 Stars
March 01, 2011
Prof Mathias Rummel talks about the history of bendamustine from its origins in 1960’s East Germany to the modern trials evaluating the use of bendamustine and rituximab to treat lymphoproliferative diseases.
Prof Antonio Palumbo - Molinette Hospital,  Turin, Italy and Prof Vincent Rajkumar - Mayo Clinic, Arizona, USA | BahVideo.com
www.ecancer.tv

Prof Antonio Palumbo - Molinette Hospital, Turin, Italy and Prof Vincent Rajkumar - Mayo Clinic, Arizona, USA

0 of 5 Stars
March 01, 2011
Prof Antonio Palumbo and Prof Vincent Rajkumar discuss some of the key research into myeloma that was presented at ASH 2010. This includes trials demonstrating that post transplant lenalidomide maintenance treatment dramatically improves progression free survival, a study comparing bortezomib ...
Prof Anton Hagenbeek - Academic Medical Center,  Amsterdam, Netherlands | BahVideo.com
www.ecancer.tv

Prof Anton Hagenbeek - Academic Medical Center, Amsterdam, Netherlands

0 of 5 Stars
February 23, 2011
Prof Anton Hagenbeek discusses the five and a half year results of the First-Line Indolent Trial (FIT) study. The randomised phase III FIT study evaluates the clinical benefits and safety of a single infusion of Zevalin (ibritumomab tiuxetan) in patients with previously untreated follicular ...
: advertisement :
Featured
Content
Featuring websites that enhance the internet user’s experience.

Like
Like